Hjem › Kronisk inflammatorisk demyeliniserende polyradikuloneuropati › Californien
Kronisk inflammatorisk demyeliniserende polyradikuloneuropati kliniske forsøg i Californien
11 studier for Kronisk inflammatorisk demyeliniserende polyradikuloneuropati søger deltagere på steder i Californien.
Byer i Californien
Officiel studietekst (engelsk)
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Site Number - 1618, Carlsbad
- Site Number - 1637, Mission Hills
- Site Number - 1619, Orange
- og 2 flere
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07032662A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
- Samir Macwan, M.D., Inc. (S corporation), Rancho Mirage
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT07091630A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
- Samir Macwan, M.D., Inc., Rancho Mirage
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT06920004A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Keck School of Medicine of University of Southern California- Site Number : 8400002, Los Angeles
- University of California Irvine Medical Center- Site Number : 8400007, Orange
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT06290141A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
- TG Therapeutics Investigational Trial Site, La Jolla
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT06680037A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- GC2402 Study Site 104, Rancho Mirage
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 4. sep. 2026 · NCT07540221A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
- Clinical Study Site, Los Angeles
- Clinical Study Site, San Francisco
- Clinical Study Site, San Francisco
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 2. sep. 2026 · NCT06858579A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases
- Hoag Memorial Hospital Presbyterian, Newport Beach
- Stanford Neuroscience Health Center, Palo Alto
RekruttererFase 1
Alder 18 til 75 · Alle køn · Opdateret 14. aug. 2026 · NCT07304154A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- University of California San Diego, La Jolla
- California Pacific Medical Center, San Francisco
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 23. apr. 2026 · NCT06798012A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- Stanford Neuroscience Health Center, Palo Alto
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 20. jan. 2026 · NCT06747351A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care
- Samir Macwan MD Inc, Rancho Mirage
- Neuro/Psych Sleep Clinic, San Francisco
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 21. nov. 2025 · NCT06538064Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.